All terms in NCIT
| Label | Id | Description |
|---|---|---|
| AKT3 Gene Alteration Positive | NCIT_C146653 | [A finding indicating that mutation, overexpression or rearrangement of the AKT3 gene has been detected in a sample.] |
| C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Since Study Start) | NCIT_C107045 | [Columbia-Suicidality Severity Rating Scale Already Enrolled Subjects (C-SSRS Already Enrolled Subjects ) Description of most severe Ideation. (Since Study Start).] |
| Seven-locus Stock, M Lyon, Harwell, 1969 | NCIT_C15017 | |
| RB1 Gene Deletion | NCIT_C146654 | [A molecular abnormality referring to the loss of at least one copy of the RB1 gene.] |
| RB1 Gene | NCIT_C17360 | [This gene is involved in the regulation of cell differentiation, growth and proliferation.] |
| C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Prior to Study Entry) | NCIT_C107046 | [Columbia-Suicidality Severity Rating Scale Already Enrolled Subjects (C-SSRS Already Enrolled Subjects ) How many times have you had these thoughts? (Prior to Study Entry).] |
| PT Mouse | NCIT_C15018 | |
| RARA Positive | NCIT_C146655 | [An indication that RARA expression has been detected in a sample.] |
| C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Since Study Start) | NCIT_C107047 | [Columbia-Suicidality Severity Rating Scale Already Enrolled Subjects (C-SSRS Already Enrolled Subjects ) How many times have you had these thoughts? (Since Study Start).] |
| Dobrovlskaia-Zavadskaia Paris, 1928 | NCIT_C15019 | |
| Body Surface | NCIT_C29667 | [The surface of an external body region.] |
| Anatomic Surface | NCIT_C34022 | [The external portion of any anatomic structure.] |
| Signal Repression | NCIT_C29668 | [Repression of any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals.] |
| H19 Imprinted Maternal Untranslated mRNA | NCIT_C29669 | [Maternally expressed exclusively and developmentally regulated human putative tumor suppressor H19 Gene encodes H19 Imprinted Maternal Untranslated mRNA. Expression in developing skeletal and smooth muscles correlates with specific differentiation events. It accumulates during skeletal muscle development with maximal adult expression and correlates with the nonproliferative, actin-positive muscle cell phenotype. Loss of H19 expression may be involved in Wilms tumorigenesis. (NCI)] |
| Decreased Concomitant Drug Half Life | NCIT_C54616 | [Decreased period of time required for the concentration or amount of a concomitant drug in the body to be reduced to exactly one-half of a given concentration or amount.] |
| Precocious Puberty, CTCAE 5.0 | NCIT_C146645 | [A disorder characterized by unusually early development of secondary sexual features; the onset of sexual maturation begins usually before age 8 for girls and before age 9 for boys.] |
| Endocrine Disorders, CTCAE | NCIT_C143166 | |
| Decreased Time To Concomitant Drug Peak Blood Concentration | NCIT_C54617 | [Decreased time following concomitant drug administration at which the peak drug blood concentration occurs.] |
| KIR2DL1 Polymorphism Positive | NCIT_C146646 | [An indication that polymorphism of the KIR2DL1 gene has been detected in a sample.] |
| SPL Type of Drug Interaction Consequence Terminology | NCIT_C54618 | [Terminology used to specify type of drug interaction consequence in the framework of the Structured Product Labeling documents.] |